Literature DB >> 19070265

Increasing deaths from opioid analgesics in the United States: an evaluation in an interventional pain management practice.

Kavita N Manchikanti1, Laxmaiah Manchikanti, Kimberly S Damron, Vidyasagar Pampati, Bert Fellows.   

Abstract

OBJECTIVE: To assess the prevalence of opioid-related deaths in patients in an interventional pain management tertiary referral center.
METHODS: Patient deaths from March 2003 to February 2007 were evaluated.
RESULTS: From March 2003 to February 2007, 2,179 patients were receiving opioids in 2003, 2,445 in 2004, 2,804 in 2005, and 2,965 in 2006, respectively. Overall, 86 percent of the patients were referred by a physician and 90 percent of patients received interventional techniques. There were a total of 91 deaths, of which 60 were categorized as natural deaths, 25 were characterized as accidental deaths, and 6 were characterized as suicidal. Of the 18 drug poisoning deaths, 5 deaths were positively related to prescription drugs, 7 deaths were probably related to prescription drugs, and 6 deaths had no relation to the prescription drugs provided. Total opioid-related deaths were 12 over this 4-year period with 0.46 in 2003, 2.04 in 2004, 2.85 in 2005, and 1.35 in 2006 per 1,000 population. In contrast, deaths definitely related to prescription opioids were 5 (0.92 per 1,000) over a period of 4 years. In the suicidal group, there were a significantly higher proportion of patients with generalized anxiety disorder.
CONCLUSIONS: In an interventional pain management practice (a tertiary referral center), the total prevalence of opioid-related deaths varied from 0.46 to 1.78 per 1,000 from 2003 to 2006 with a total of 12 deaths over a period of 4 years. The deaths definitely related to opioidprescriptions were 5 with a rate of 0 to 1.43 per 1,000 over a period of 4 years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070265     DOI: 10.5055/jom.2008.0031

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  9 in total

Review 1.  An examination of the observed placebo effect associated with the treatment of low back pain - a systematic review.

Authors:  Aaron A Puhl; Christine J Reinhart; Elizabeth R Rok; H Stephen Injeyan
Journal:  Pain Res Manag       Date:  2011 Jan-Feb       Impact factor: 3.037

2.  Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Authors:  Merav Kovatch; Daniel Feingold; Odelia Elkana; Shaul Lev-Ran
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-23       Impact factor: 4.035

3.  Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.

Authors:  Jason R Healy; Padmavani Bezawada; Jihyun Shim; Jace W Jones; Maureen A Kane; Alexander D MacKerell; Andrew Coop; Rae R Matsumoto
Journal:  ACS Chem Neurosci       Date:  2013-06-11       Impact factor: 4.418

Review 4.  Urine Drug Testing in Cancer Pain Management.

Authors:  Joseph A Arthur
Journal:  Oncologist       Date:  2019-10-11

5.  Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use.

Authors:  Susan L Calcaterra; Traci E Yamashita; Sung-Joon Min; Angela Keniston; Joseph W Frank; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

6.  Reduced post-operative opioid use decreases length of stay and readmission rates in patients undergoing hip and knee joint arthroplasty.

Authors:  Michael J Schlosser; Kimberly M Korwek; Reginald Dunn; Russell E Poland
Journal:  J Orthop       Date:  2020-03-24

Review 7.  A Mind-Body Approach to Pediatric Pain Management.

Authors:  Melanie L Brown; Enrique Rojas; Suzanne Gouda
Journal:  Children (Basel)       Date:  2017-06-20

8.  Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?

Authors:  Igor Kissin
Journal:  J Pain Res       Date:  2013-07-04       Impact factor: 3.133

9.  A Case Report of Clonazepam Dependence: Utilization of Therapeutic Drug Monitoring During Withdrawal Period.

Authors:  Ivana Kacirova; Milan Grundmann; Petr Silhan; Hana Brozmanova
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.